Biotech Blog

This is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so, you may respond in the comments section below.
The recent editorial on “Intellectual property and biotechnology innovation: To protect or not protect” by Dr Yali Friedman, Managing Editor of the Journal of Commercial Biotechnology was thought [...]

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology:
Why data exclusivity is the new patent protection
Peter J Pitts, Center for medicine in the public interest
Follow-on biologic drug competition – No [...]

In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products must “differ significantly in properties with regard to efficacy.” This requirement for a significant improvement in efficacy only applies to drugs — not to other patentable inventions like pens, car engines, etc., and is of [...]

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in December 2008
*Drugs may be covered by multiple patents

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in November 2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

ALKERAN
Glaxosmithkline
melphalan hydrochloride
4,997,651
Nov 18, 2008

BREVIBLOC
Baxter Hlthcare Corp
esmolol hydrochloride
5,017,609
Nov 21, 2008

BUSPAR
Bristol Myers Squibb
buspirone hydrochloride
5,015,646
Nov 14, 2008

COVERA-HS
Gd Searle Llc
verapamil hydrochloride
5,030,456
Nov 7, 2008

DYNACIRC CR
Smithkline Beecham
isradipine
5,030,456
Nov 7, 2008

NEUROLITE
Lantheus Medcl
technetium tc-99m bicisate kit
5,279,811
Nov 23, 2008

NEURONTIN
Parke Davis
gabapentin
4,894,476
Nov 2, 2008

NEURONTIN
Pfizer Pharms
gabapentin
4,894,476
Nov 2, 2008

NUVIGIL
Cephalon
armodafinil
4,927,855
Nov 22, 2008

PRELAY
Sankyo
troglitazone
4,572,912
Nov 9, 2008

REZULIN
Pfizer [...]

Guest content from John Avellanet, managing director and principal of Cerulean Associates:

Intellectual Property Theft on the Rise

By John Avellanet, Managing Director and Principal of Cerulean Associates LLC
Reprinted with permission from SMARTERCOMPLIANCE™ 2(9): p 1-2 (September 2008)
Nine out of ten companies do not have appropriate policies and controls in place to stop employees, contractors or [...]

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in October2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

CASODEX
Astrazeneca
bicalutamide
4,636,505
Oct 1, 2008

CONDYLOX
Watson Pharms
podofilox
5,057,616
Oct 15, 2008

COSOPT
Merck
dorzolamide hydrochloride; timolol maleate
4,797,413
Oct 28, 2008

ELIGARD
Qlt Usa
leuprolide acetate
4,938,763
Oct 3, 2008

ELIGARD
Qlt Usa
leuprolide acetate
5,733,950
Oct 3, 2008

ELIGARD
Qlt Usa
leuprolide acetate
5,739,176
Oct 3, 2008

ELIGARD
Qlt Usa
leuprolide acetate
RE37950
Oct 3, 2008

FERIDEX I.V.
Amag Pharms Inc
ferumoxides
5,055,288
Oct 8, 2008

GASTROMARK
Amag Pharms Inc
ferumoxsil
5,055,288
Oct 8, 2008

IONSYS
Alza
fentanyl hydrochloride
5,232,438
Oct 3, 2008

MIRCETTE
Duramed
desogestrel; ethinyl [...]

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in September 2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

ANDRODERM
Watson Labs
testosterone
4,855,294
Sep 6, 2008

AVITA
Mylan Bertek
tretinoin
5,045,317
Sep 3, 2008

DDAVP
Sanofi Aventis Us
desmopressin acetate
5,047,398
Sep 10, 2008

OPANA ER
Endo Pharms
oxymorphone hydrochloride
5,128,143
Sep 19, 2008

RESCULA
R Tech Ueno Ltd
unoprostone isopropyl
5,001,153
Sep 19, 2008

Courtesy of DrugPatentWatch.com

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in August 2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

ADVAIR DISKUS 100/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
4,992,474
Aug 12, 2008

ADVAIR DISKUS 100/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
5,126,375
Aug 12, 2008

ADVAIR DISKUS 100/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
5,225,445
Aug 12, 2008

ADVAIR DISKUS 250/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
4,992,474
Aug 12, 2008

ADVAIR DISKUS 250/50
Glaxosmithkline
fluticasone propionate; salmeterol xinafoate
5,126,375
Aug 12, 2008

ADVAIR DISKUS 250/50
Glaxosmithkline
fluticasone propionate; [...]

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in July 2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

CARDIOLITE
Bristol Myers Squibb
technetium tc-99m sestamibi kit
4,988,827
Jul 29, 2008

DEPAKOTE
Abbott
divalproex sodium
4,988,731
Jul 29, 2008

DEPAKOTE
Abbott
divalproex sodium
5,212,326
Jul 29, 2008

DEPAKOTE CP
Abbott
divalproex sodium
4,988,731
Jul 29, 2008

DEPAKOTE CP
Abbott
divalproex sodium
5,212,326
Jul 29, 2008

DEPAKOTE ER
Abbott
divalproex sodium
4,988,731
Jul 29, 2008

DEPAKOTE ER
Abbott
divalproex sodium
5,212,326
Jul 29, 2008

GLUCOTROL XL
Pfizer
glipizide
5,545,413
Jul 2, 2008

HIVID
Roche
zalcitabine
5,028,595
Jul 2, 2008

RESTORIL
Tyco Hlthcare
temazepam
5,030,632
Jul 9, 2008

RESTORIL
Tyco Hlthcare
temazepam
5,326,758
Jul [...]